|Phone||+1 (781) 373-1636|
|Partial Close, 1/2012 ||$781k|
|Series B, 2/2014 |
Respiratory Motion, Inc. (RMI) is a new generation medical device company developing and commercializing the ExSpironTM. RMI’s goal is to cost-effectively improve the standard of care in respiration monitoring. Ventilation monitoring is increasingly recommended as oxygen saturation levels inadequately predict ventilatory distress.